Dietary Supplement Label Database

200 mg DHA Gel Capsule

Off market
Photo of the Centrix Pharmaceutical 200 mg DHA Gel Capsule label
Photo of the label, from the NIH's original record · Open full size ↗
Supplement Facts
Serving Size 1 Softgel(s)
Amount Per Serving% Daily Value
Docosahexaenoic Acid200 mg

Other ingredients: Gelatin, Glycerin, Water

% Daily Values for: Pregnant and Lactating.

Where this label comes from

An original label of the NIH's Dietary Supplement Label Database, entered there on 25 March 2021, shown here as it was entered. The NIH's record

General information

Product name
200 mg DHA Gel Capsule
Brand
Centrix Pharmaceutical
Barcode (UPC)
Not printed
Net contents
6 5-day Blister Pack(s)
Market status
Off market
DSLD ID
245691

Classification

Supplement form
Softgel Capsule
Product type
Fat/Fatty Acid
Claim types on the label
Nutrient, All Other, Structure/Function
Intended for
Pregnant Women, Adult Female (18 - 50 Years), Lactating

Label statements

FDA Statement of Identity: Maternal Nutritional Supplement

Formula: Contains: An Rx Prenatal Vitamin and Omega-3 Docosahexaenoic Acid (DHA) Rx prenatal vitamin tablet and 200 mg DHA gel capsule

Formula: Contains: Gel capsules contain a highly purified pharmaceutical grade DHA

Directions: Dosage and administration: One tablet and one softgel daily with or without food, or as prescribed by a licensed health care provider with prescribing authority.

Precautions: Children: Keep out of reach of children.

Storage: Storage: Store at controlled room temperature 20 degrees-25 degrees Celsius (68 degrees-77 degrees Fahrenheit). Excursions permitted to 15 degrees-30 degrees Celsius (59 degrees-86 degrees Fahrenheit).

Formula: Contains: Description: Paire OB Plus DHA is a prescription prenatal/postnatal multivitamin/mineral tablet and a gel capsule of an essential fatty acid.

Precautions: All Other: Contraindications: This product is contraindicated in patients with a known hypersensitivity to any of the ingredients. Warning: Ingestion of more than 3 grams of omega-3 fatty acids per day has been shown to have potential antithrombotic effects, including an increased bleeding time and International Normalized Ratio (INR). Administration of omega-3 fatty acids should be avoided in patients taking anticoagulants and in those known to have an inherited of acquired predisposition to bleeding diathesis.

Brand information

Manufacturer: Centrix Pharmaceutical, Inc., Birmingham, AL, USA

More labels from Centrix Pharmaceutical

Every Centrix Pharmaceutical label ›

Labels only: each label is shown as printed on the bottle, with no grades, rankings or advice. A label in this database is not an endorsement of the product. Read the label on the bottle you buy: makers change their formulas. Reverse Age Lab is not affiliated with, or endorsed by, the National Institutes of Health or its Office of Dietary Supplements. The original labels come from the NIH’s public-domain data; the labels since are read by us. Search the Dietary Supplement Label Database.